These 10 scientists are leading a new generation of gene editors developing CRISPR medicines

After the approval of Casgevy, therapeutic gene editing looks to expand

November 1, 2024 Check out STAT+

Sponsored By

Photo illustration: Christine Kao/STAT; Photos: Michelle Fredricks, Peggy Peterson, Suzanne Kreiter/Globe Staff STAT+ | These 10 scientists are leading a new generation of gene editors developing CRISPR medicines STAT series looks at movers and shakers in the life sciences. Here are 10 scientists developing new therapeutic applications of CRISPR By Megan Molteni STAT+ | Warren wants close FTC scrutiny of drug distributors buying cancer medical groups Elizabeth Warren argues that patients could lose in deals that get middlemen McKesson, Cardinal Health, and Cencora into cancer care. By Bob Herman STAT+ | Amid divorce from Dana-Farber, Mass General Brigham touts its own cancer institute Amid its divorce from Dana-Farber Cancer Institute, MGB is trumpeting its own cancer institute, which will combine resources of its two flagship hospitals. By Jonathan Saltzman — Boston Globe

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser